Society of Interventional Radiology Inducts New Fellows

The Society of Interventional Radiology (SIR) inducted 16 new Fellows during its Annual Scientific Meeting, March 4–9, in Phoenix. This honor, achieved by only 15 percent of eligible SIR members, is bestowed to those who have demonstrated excellence in interventional radiology by virtue of research and published works, teaching, and leadership within the field, along with contributions and involvement within the society.

The newly inducted SIR Fellows are:

California

Barbara N. Hamilton, MD, FSIR, Desert Regional Medical Center, Palm Springs

Dayantha M. Fernando, II, MD, FSIR, University of California Irvine, Orange

Georgia

Neil J. Resnick, MD, FSIR, Emory University School of Medicine, Atlanta

Massachusetts

Allan I. Hoffman, MD, FSIR, Commonwealth Radiology Associates, Andover

Hirschel D. McGinnis, MD, FSIR, Steward Medical Group, Taunton

Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center, Boston

Salomao Faintuch, MD, MS, FSIR, Beth Israel Deaconess Medical Center, Boston

New Hampshire

John M. Gemery, MD, FSIR, Dartmouth Hitchcock Medical Center, Lebanon

New York

Joseph P. Erinjeri, MD, PhD, FSIR, Memorial Sloan Kettering Cancer Center, New York

Stuart J. Singer, MD, FSIR, Syracuse VAMC, Syracuse

Talia Sasson, MD, FSIR, University of Rochester, Rochester

Pennsylvania

Paul S. Brady, MD, FSIR, Albert Einstein Medical Center, Philadelphia

Texas

Maria Del Pilar Bayona Molano, MD, FSIR, University of Texas Southwestern, Dallas

Steven Y. Huang, MD, FSIR, MD Anderson Cancer Center, Houston

Wisconsin

Derrick R. Siebert, MD, FSIR, Aspirus Wausau Hospital, Wausau

Matthew J. Scheidt, MD, FSIR, Medical College of Wisconsin, Milwaukee

West Virginia
Amy R. Deipolyi, MD, FSIR, West Virginia University, Charleston

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.